Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

AMRN Amarin Corp Plc

Price (delayed)

$15.82

Market cap

$327.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.4

Enterprise value

$215.74M

Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its ...

Highlights
AMRN's quick ratio is up by 26% year-on-year and by 3% since the previous quarter
AMRN's debt is down by 5% year-on-year but it is up by 2.8% since the previous quarter
The company's EPS has shrunk by 69% YoY and by 10% QoQ
AMRN's net income has plunged by 67% YoY and by 7% from the previous quarter

Key stats

What are the main financial stats of AMRN
Market
Shares outstanding
20.71M
Market cap
$327.62M
Enterprise value
$215.74M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.69
Price to sales (P/S)
1.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.01
Earnings
Revenue
$214.11M
Gross profit
$74.61M
Operating income
-$94.97M
Net income
-$87.93M
EBIT
-$81.66M
EBITDA
-$78.68M
Free cash flow
-$30.88M
Per share
EPS
-$4.4
EPS diluted
-$4.4
Free cash flow per share
-$1.49
Book value per share
$22.87
Revenue per share
$10.36
TBVPS
$30.96
Balance sheet
Total assets
$655.68M
Total liabilities
$181.99M
Debt
$7.94M
Equity
$473.69M
Working capital
$410.65M
Liquidity
Debt to equity
0.02
Current ratio
3.53
Quick ratio
2.39
Net debt/EBITDA
1.42
Margins
EBITDA margin
-36.7%
Gross margin
34.8%
Net margin
-41.1%
Operating margin
-44.4%
Efficiency
Return on assets
-12.2%
Return on equity
-17.2%
Return on invested capital
-22.3%
Return on capital employed
-16.6%
Return on sales
-38.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMRN stock price

How has the Amarin stock price performed over time
Intraday
0.19%
1 week
-6.56%
1 month
18.68%
1 year
0.13%
YTD
63.09%
QTD
-2.47%

Financial performance

How have Amarin's revenue and profit performed over time
Revenue
$214.11M
Gross profit
$74.61M
Operating income
-$94.97M
Net income
-$87.93M
Gross margin
34.8%
Net margin
-41.1%

AMRN financials

AMRN's net margin has dropped by 116% year-on-year and by 14% since the previous quarter
AMRN's operating margin has dropped by 93% year-on-year and by 10% since the previous quarter
AMRN's net income has plunged by 67% YoY and by 7% from the previous quarter
Amarin's gross profit has shrunk by 50% YoY and by 8% QoQ

Price vs fundamentals

How does AMRN's price correlate with its fundamentals

AMRN Price vs fundamentals

AMRN Earnings waterfall

AMRN Price vs fair value

Growth

What is Amarin's growth rate over time

AMRN growth chart

Valuation

What is Amarin stock price valuation
P/E
N/A
P/B
0.69
P/S
1.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.01

Valuation vs average

Price to earnings (P/E)

The company's EPS has shrunk by 69% YoY and by 10% QoQ

Price to book (P/B)

AMRN's P/B is 54% below its 5-year quarterly average of 1.5 but 38% above its last 4 quarters average of 0.5
The equity has declined by 13% year-on-year and by 2.6% since the previous quarter

Price to sales (P/S)

The P/S is 53% more than the last 4 quarters average of 1.0 but 15% less than the 5-year quarterly average of 1.8
The revenue is down by 23% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Amarin business performance
The company's return on sales has shrunk by 115% YoY and by 13% QoQ
Amarin's ROA has plunged by 94% YoY and by 12% from the previous quarter
AMRN's ROE has plunged by 81% YoY and by 11% from the previous quarter
The ROIC has shrunk by 53% YoY and by 4.2% QoQ

Dividends

What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRN.

Financial health

How did Amarin financials performed over time

Assets vs liabilities

AMRN's quick ratio is up by 26% year-on-year and by 3% since the previous quarter
AMRN's total liabilities is down by 25% year-on-year and by 9% since the previous quarter

Debt vs equity

AMRN's debt is 98% smaller than its equity
The equity has declined by 13% year-on-year and by 2.6% since the previous quarter
AMRN's debt is down by 5% year-on-year but it is up by 2.8% since the previous quarter

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.